| Technology in Parkinson's disease: challenges and opportunities AJ Espay, P Bonato, FB Nahab, W Maetzler, JM Dean, J Klucken, ... Movement Disorders 31 (9), 1272-1282, 2016 | 614 | 2016 |
| OOP RNA, produced from multicopy plasmids, inhibits lambda cII gene expression through an RNase III-dependent mechanism. L Krinke, DL Wulff Genes & Development 1 (9), 1005-1013, 1987 | 136 | 1987 |
| RNase III-dependent hydrolysis of lambda cII-O gene mRNA mediated by lambda OOP antisense RNA. L Krinke, DL Wulff Genes & development 4 (12a), 2223-2233, 1990 | 113 | 1990 |
| The cleavage specificity of RNase III L Krinke, DL Wulff Nucleic acids research 18 (16), 4809-4815, 1990 | 90 | 1990 |
| Transcranial magnetic stimulation, deep brain stimulation, and other forms of neuromodulation for substance use disorders: Review of modalities and implications for treatment JJ Mahoney III, CA Hanlon, PJ Marshalek, AR Rezai, L Krinke Journal of the neurological sciences 418, 117149, 2020 | 87 | 2020 |
| Charting the road forward in psychiatric neurosurgery: proceedings of the 2016 American Society for Stereotactic and Functional Neurosurgery workshop on neuromodulation for … AA Bari, CB Mikell, A Abosch, S Ben-Haim, RJ Buchanan, AW Burton, ... Journal of Neurology, Neurosurgery & Psychiatry 89 (8), 886-896, 2018 | 77 | 2018 |
| The role of the OOP antisense RNA in coliphage λ development L Krinke, M Mahoney, DL Wulff Molecular microbiology 5 (5), 1265-1272, 1991 | 48 | 1991 |
| Ultrasound diagnostic and therapy management system and associated method J Alford, SM Goetz, L Krinke, MS Lent, ER Scott, XK Wei, JD Welter US Patent 11,167,154, 2021 | 37 | 2021 |
| Physiologically informed neuromodulation K Wendt, T Denison, G Foster, L Krinke, A Thomson, S Wilson, AS Widge Journal of the Neurological Sciences 434, 120121, 2022 | 16 | 2022 |
| Proceedings of the 10th annual deep brain stimulation think tank: Advances in cutting edge technologies, artificial intelligence, neuromodulation, neuroethics, interventional … JK Wong, HS Mayberg, DD Wang, RM Richardson, CH Halpern, L Krinke, ... Frontiers in Human Neuroscience 16, 1084782, 2023 | 9 | 2023 |
| Non-continuous electrical stimulation therapy RS Raike, TJ Denison, SM Goetz, WJ George, JE Giftakis, L Krinke, ... US Patent App. 15/926,113, 2019 | 4 | 2019 |
| Methods and devices for improved efficiency of RNA delivery to cells DR Thakker, CA Schu, EN Burright, PW Wacnik, JM Heisel, L Krinke US Patent 8,207,138, 2012 | 2 | 2012 |
| Proceedings of the 11th Annual Deep Brain Stimulation Think Tank: pushing the forefront of neuromodulation with functional network mapping, biomarkers for adaptive DBS … KA Johnson, NUF Dosenbach, EM Gordon, CG Welle, KB Wilkins, ... Frontiers in Human Neuroscience 18, 1320806, 2024 | 1 | 2024 |
| Method and devices for improved efficiency of rna delivery to cells DR Thakker, CA Shu, EN Burright, PW Wacnik, JM Heisel, L Krinke US Patent App. 12/782,274, 2010 | 1 | 2010 |
| Transcranial Magnetic Stimulation (TMS) Apparatus L Krinke, E Granstrom US Patent App. 18/037,499, 2024 | | 2024 |
| Takashi Morishita, Fukuoka University, Japan Y Salimpour, M Hariz, JK Wong, JK Wong, HS Mayberg, DD Wang, ... | | 2023 |
| Lambda OOP RNA initiates messenger-RNA degradation at the 3'-end of the cII gene through an RNASE III dependent mechanism. L Krinke | | 1990 |
| Lambda OOP RNA Initiates MRNA Degradation at the 3ʼ-end of the CII Gene Through an RNASE III Dependent Mechanism L Krinke University at Albany, State University of New York, Department of Biological …, 1989 | | 1989 |
